Small Lymphocytic Lymphoma (SLL) / Untreated Chronic Lymphocytic Leukemia (CLL)

2 total trials 1 recruiting

Filter these 2 trials by phase, country, sponsor and more.

Open in Search →

A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator’s Choice of Ibrutinib or Acalabrutinib) in Participants … Not authorised

2022-501697-19-00 5
A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator’s Choice of Ibrutinib or Acalabrutinib) in Participants … Recruiting

2022-501697-19-01 5 2024-06-18

Showing 1–2 of 2 trials